Is Neogenomics Inc (NEO) positioned for future growth?

With 1.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.13 million shares. The 52-week range on NEO shows that it touched its highest point at $19.11 and its lowest point at $8.98 during that stretch. It currently has a 1-year price target of $18.67. Beta for the stock currently stands at 1.43.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEO was up-trending over the past week, with a rise of 16.49%, but this was down by -19.11% over a month. Three-month performance dropped to -36.71% while six-month performance fell -32.17%. The stock lost -31.83% in the past year, while it has lost -33.98% so far this year. A look at the trailing 12-month EPS for NEO yields -0.62 with Next year EPS estimates of 0.35. For the next quarter, that number is -0.01. This implies an EPS growth rate of 60.61% for this year and 98.79% for next year.

Float and Shares Shorts:

At present, 128.15 million NEO shares are outstanding with a float of 126.92 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEO since 8 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.12006 being high and $0.08731822 being low. For NEO, this leads to a yearly average estimate of $0.098233. Based on analyst estimates, the high estimate for the next quarter is $0.07 and the low estimate is $0.03. The average estimate for the next quarter is thus $0.05.